14 Tan JS, Wang JJ, Liew G, et al. Ageª²related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol 2008;92(4):509ª²512

15 Fraserª²Bell S, Wu J, Klein R, et al. Cardiovascular risk factors and ageª²related macular degeneration: the Los Angeles Latino Eye Study. Am J Ophthalmol 2008;145(2):308ª²316

16 Neuringer M, Anderson GJ, Connor WE. The essentiality of nª²3 fatty acids for the development and function of the retina and brain. Annu Rev Nutr 1988;8:517ª² 541

17 Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omegaª²3 fatty acid intake, and associations with ageª²related macular degeneration: the US Twin Study of Ageª²Related Macular Degeneration. Arch Ophthalmol 2006;124(7):995ª²1001

18 Alvarez RA, Liou GI, Fong SL, et al. Levels of alphaª² and gammaª²tocopherol in human eyes: evaluation of the possible role of IRBP in intraocular alphaª²tocopherol transport. Am J Clin Nutr 1987;46(3):481ª² 487

19 Lu L, Hackett SF, Mincey A, et al. Effects of different types of oxidative stress in RPE cells. J Cell Physiol 2006;206(1):119ª²125

20 Belda JI, Roma J, Vilela C, et al. Serum vitamin E levels negatively correlate with severity of ageª²related macular degeneration. Mech Ageing Dev 1999;107(2):159ª²164

21 SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with ageª²related macular degeneration in a caseª²control study: AREDS Report No. 22. Arch Ophthalmol 2007;125(9):1225ª²1232

22 Souied EH, Leveziel N, Richard F, et al. Y402H complement factor H polymorphism associated with exudative ageª²related macular degeneration in the French population. Mol Vis 2005;11:1135ª²1140

23 Baird PN, Islam FM, Richardson AJ, et al. Analysis of the Y402H variant of the complement factor H gene in ageª²related macular degeneration. Invest Ophthalmol Vis Sci 2006;47(10):4194ª² 4198

24 Lau LI, Chen SJ, Cheng CY, et al. Association of the Y402H polymorphism in complement factor H gene and neovascular ageª²related macular degeneration in Chinese patients. Invest Ophthalmol Vis Sci 2006;47(8):3242ª²3246

25 Gotoh N, Yamada R, Hiratani H, et al. No association between complement factor H gene polymorphism and exudative ageª²related macular degeneration in Japanese. Hum Genet 2006;120(1):139ª²143

26 Yates JR, Sepp T, Matharu BK, et al. Complement C3 variant and the risk of ageª²related macular degeneration. N Engl J Med 2007;357(6):553ª²561

27 Mullerª²Eberhard HJ. Molecular organization function of the complement system. Annu Rev Biochem 1988;57:321ª²347

28 Sivaprasad S,Adewoyin T,Bailey TA, et al. Estimation of systemic complement C3 activity in ageª²related macular degeneration. Arch Ophthalmol 2007;125(4):515ª²519

29 Maller J, George S, Purcell S, et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of ageª²related macular degeneration. Nat Genet 2006;38(9):1055ª²1059

30 Jakobsdottir J, Conley YP, Weeks DE, et al. C2 and CFB genes in ageª²related maculopathy and joint action with CFH and LOC387715 genes. PLoS ONE 2008;3(5):e2199

31 Gibbs D, Yang Z, Constantine R, et al. Further mapping of 10q26 supports strong association of HTRA1 polymorphisms with ageª²related macular degeneration. Vision Res 2008;48(5):685ª² 689

32 Yang Z, Camp NJ, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to ageª²related macular degeneration. Science 2006;314(5801):992ª²993

33 Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in wet ageª²related macular degeneration. Science 2006;314(5801):989ª²992

34 Cameron DJ, Yang Z, Gibbs D, et al. HTRA1 variant confers similar risks to geographic atrophy and neovascular ageª²related macular degeneration. Cell Cycle 2007;6(9):1122ª²1125

35 Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for ageª²related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005;14(21):3227ª²3236

36 Franke TF, Hornik CP, Segev L, et al. PI3K/Akt and apoptosis: size matters. Oncogene 2003;22(56):8983ª² 8998

37ÀîÏÄ£¬ÍõÓêÉú.PegaÖÎÁÆʪÐÔÄêÁäÏà¹ØÐԻư߱äÐÔµÄÁÙ´²Ñо¿.¹ú¼ÊÑÛ¿ÆÔÓÖ¾2006;6(4):829ª² 832

38 Richardson AJ, Islam FM, Guymer RH, et al. A tagª²single nucleotide polymorphisms approach to the vascular endothelial growth factorª²A gene in ageª²related macular degeneration. Mol Vis 2007;13:2148ª²2152

39 Lin JM,Wan L,Tsai YY, et al. Vascular endothelial growth factor gene polymorphisms in ageª²related macular degeneration. Am J Ophthalmol 2008;145(6):1045ª²1051

40 Tsimikas S, Willerson JT, Ridker PM. Cª²reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 2006;47(8 Suppl):C19ª²31

41 Schaumberg DA, Christen WG, Kozlowski P, et al. A prospective assessment of the Y402H variant in complement factor H, genetic variants in Cª²reactive protein, and risk of ageª²related macular degeneration. Invest Ophthalmol Vis Sci 2006;47(6):2336ª²2340

42 Kikuchi M, Nakamura M, Ishikawa K, et al. Elevated Cª²reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular ageª²related macular degeneration. Ophthalmology 2007;114(9):1722ª²1727

43 Johnson PT, Betts KE, Radeke MJ, et al. Individuals homozygous for the ageª²related macular degeneration riskª²conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci USA 2006;103(46):17456ª²17461

ÉÏÒ»Ò³  [1] [2] [3]